tradingkey.logo

Inotiv Inc

NOTV
View Detailed Chart

1.920USD

-0.090-4.48%
Close 08/01, 16:00ETQuotes delayed by 15 min
65.95MMarket Cap
LossP/E TTM

Inotiv Inc

1.920

-0.090-4.48%
Intraday
1m
30m
1h
D
W
M
D

Today

-4.48%

5 Days

-13.51%

1 Month

-8.13%

6 Months

-56.66%

Year to Date

-53.62%

1 Year

+14.97%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts
BUY
Current Rating
5.500
Target Price
186.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Inotiv Inc
NOTV
3
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(3)
Buy(0)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.016
Neutral
RSI(14)
44.641
Neutral
STOCH(KDJ)(9,3,3)
35.331
Sell
ATR(14)
0.199
High Vlolatility
CCI(14)
-42.512
Neutral
Williams %R
72.222
Sell
TRIX(12,20)
-0.009
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.036
Sell
MA10
2.084
Sell
MA20
2.021
Sell
MA50
2.194
Sell
MA100
2.214
Sell
MA200
2.886
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Ticker SymbolNOTV
CompanyInotiv Inc
CEOMr. Robert W. Leasure, Jr.
Websitehttps://www.inotiv.com/
KeyAI